Package 0187-0453-02

Brand: zelapar

Generic: selegiline hydrochloride
NDC Package

Package Facts

Identity

Package NDC 0187-0453-02
Digits Only 0187045302
Product NDC 0187-0453
Product ID 0187-0453_f8d8f532-d8a6-4eff-baab-325fed820cdb
Description

6 POUCH in 1 CARTON (0187-0453-02) / 10 TABLET, ORALLY DISINTEGRATING in 1 POUCH

Marketing

Marketing Status
Marketed Since 2006-06-14
Brand zelapar
Generic selegiline hydrochloride
Sample Package No

Linked Drug Pages (1)

ZELAPAR ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "f8d8f532-d8a6-4eff-baab-325fed820cdb", "openfda": {"unii": ["6W731X367Q"], "rxcui": ["859190", "859192"], "spl_set_id": ["380d7717-2a79-42f3-a712-efe5e7696ba0"], "manufacturer_name": ["Bausch Health US, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "6 POUCH in 1 CARTON (0187-0453-02)  / 10 TABLET, ORALLY DISINTEGRATING in 1 POUCH", "package_ndc": "0187-0453-02", "marketing_start_date": "20060614"}], "brand_name": "ZELAPAR", "product_id": "0187-0453_f8d8f532-d8a6-4eff-baab-325fed820cdb", "dosage_form": "TABLET, ORALLY DISINTEGRATING", "pharm_class": ["Monoamine Oxidase Inhibitor [EPC]", "Monoamine Oxidase Inhibitors [MoA]", "Monoamine Oxidase Type B Inhibitor [EPC]", "Monoamine Oxidase-B Inhibitors [MoA]"], "product_ndc": "0187-0453", "generic_name": "SELEGILINE HYDROCHLORIDE", "labeler_name": "Bausch Health US, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ZELAPAR", "active_ingredients": [{"name": "SELEGILINE HYDROCHLORIDE", "strength": "1.25 mg/1"}], "application_number": "NDA021479", "marketing_category": "NDA", "marketing_start_date": "20060614", "listing_expiration_date": "20261231"}